Navigation Links
AstraZeneca Recognized as One of Working Mother's '100 Best Companies' for the Sixth Consecutive Year
Date:9/25/2007

WILMINGTON, Del., Sept. 25 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN), a global leader in the pharmaceutical industry, has been named one of the "100 Best Companies" to work for by Working Mother magazine for the sixth consecutive year, an honor that recognizes the company's commitment to work-life balance, retention and advancement of working women.

AstraZeneca provides extensive benefits designed to keep its employees happy and healthy, and this year, the company received particular recognition from Working Mother for its flexible work arrangements and day care benefits. Employee network groups for parents and caregivers, telecommuting options, parental leaves and compressed workweeks are other programs that contribute to a supportive working culture for mothers at AstraZeneca.

AstraZeneca's day care center, which offers full and part-time care for young children and infants and a summer day camp, before and after school and holiday care for school-age children, was highlighted along with the company's adoption benefits. The company subsidizes 90 percent of the cost for up to 10 days of back-up in-home or center-based childcare for well and sick children per year for all of its U.S. employees. The program is also available to employees who must take time off from work to care for their elderly parents.

"AstraZeneca's mission is focused on patient health, and that includes the health and well-being of our employees and a workplace environment that supports them both professionally and personally," said Tony Zook, President and CEO, AstraZeneca Pharmaceuticals LP, U.S. "We understand working mothers, like many employees, have responsibilities that go far beyond the office walls, and we do our best to support their distinct needs."

Carol A. Richards, District Sales Manager for AstraZeneca, explained how a job sharing arrangement she requested while pregnant allowed her to work three days a week and maintain her managerial role. W
'/>"/>

SOURCE AstraZeneca
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Astrazenecas Investigational Cancer Therapies Revealed at ASCO
2. Time magazine has recognized efforts of two Indian doctors towards reducing infant mortality rate
3. Nurse Practitioners Are Not Recognized By Medicare
4. Scientist Recognized for Drug Addiction Research
5. Medical Center Recognized for Excellence in Bariatric Surgery
6. A young scientist recognized for biomechanics innovations
7. Distinguishable Traits of Fatal Skin Cancer Recognized
8. Bipolar Spectrum Disorder may Be Under-recognized for Spectrum Disorder: Study
9. The Cancer Rumour mill working over time
10. Working in shifts may cause damage to your health
11. Junior Doctors Working Long Hours May Perform Poorly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... DiscountFurnaceFilter.com, the number one solution for homeowner’s ... Compressor Saver kit at an exceptional price. The 5-2-1 Compressor ... air conditioning unit during start up, saving wear and tear ... unit burn out. , The 5-2-1 Compressor Saver ... uses less power to start and drastically reduces the rush ...
(Date:6/19/2013)... Guests at the Residence Inn Scottsdale Paradise Valley ... go to bed or rise early thanks to a new ... , Crafty travelers will have a little extra change in ... Paradise Valley hotel’s Book Early and Save Up to ... notice, guests can enjoy the year-round Scottsdale sunshine in deluxe ...
(Date:6/19/2013)... Many trying-to-conceive couples seek medical intervention ... to a recent study published in ... of this research confirm what Fairhaven Health has ... that trying-to-conceive women would benefit from tracking ovulation, ... Fairhaven Health is a leading provider of ovulation ...
(Date:6/19/2013)... disease Amyotrophic lateral sclerosis (ALS), also known as Lou ... can be classified into four distinct stages, report pathologists ... of Pennsylvania in the Annals of Neurology . ... tissues shows, for the first time, how the fatal ... the central nervous system to other regions of brain ...
(Date:6/19/2013)... Elsevier, a world-leading provider of scientific, technical ... the publication of the National Osteoporosis Guideline Group ... osteoporosis in postmenopausal women and older men in ... 2009 in Maturitas , the original guidelines ... timely with an additional focus on the management ...
Breaking Medicine News(10 mins):Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 2Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 3Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 4Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 2Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 4Health News:Staging system in ALS shows potential tracks of disease progression, Penn study finds 2
... March 13, 2012Imagine that you have asthma, and rather than give ... have an attack, your doctor invites you to help write them? ... managing their health care, and would that ultimately make them happier ... Samir Gupta, a respirologist at St. Michael,s Hospital. His research ...
... each year in the United States because of mistakes made ... before a stoplight intersection where the traffic light turns yellow ... ahead. New research at Oregon State University will help ... then use than information, along with advanced technology that can ...
... topical gel now available by prescription significantly decreases the amount ... that is a common precursor to skin cancer, according to ... of Medicine. The gel, called ingenol mebutate, is applied ... quicker and even more effective as current therapies require weeks ...
... WEDNESDAY, March 14 (HealthDay News) -- A newly approved gel ... is a common precursor to squamous cell skin cancer, a ... even months to treat the condition, but the new product ... matter of days, according to the report in the March ...
... HealthDay Reporter , WEDNESDAY, March 14 (HealthDay News) ... beat back a genetic predisposition to be overweight, compared to ... research suggests. The findings don,t prove that the exercise ... possible that something else could explain why those who walked ...
... appetite can be a fleeting queasiness or continue to the ... is going on inside the head. ,New findings are emerging ... of appetite, and the systems in place to avoid starvation. ... brain circuit that mediates the loss of appetite in mice. ...
Cached Medicine News:Health News:St. Michael's doctor uses wiki to empower patients and help them to develop asthma action plans 2Health News:The 'twilight zone' of traffic costs lives at stoplight intersections 2Health News:New drug now available for actinic keratosis 2Health News:New Gel Treats Precancerous Skin Condition in Days: Study 2Health News:Brisk Daily Walk Could Counter 'Obesity Genes' 2Health News:Loss of appetite deciphered in brain cell circuit 2Health News:Loss of appetite deciphered in brain cell circuit 3
(Date:6/19/2013)... , June 19, 2013 A decade-long ... in Helmholtz Zentrum München, Germany , ... autoantibodies and the risk of developing type 1 diabetes ... preventions for the disease. The study, "Seroconversion to Multiple ... Children," was published today in The Journal of ...
(Date:6/19/2013)... --  Voices Against Brain Cancer (VABC), a not-for-profit ... today announced that it has awarded Tocagen Inc. ( ... of Toca 511 & Toca FC in patients diagnosed ... 3 or Grade 4).  Tocagen is a privately held ... an initial focus on brain cancer. "Every ...
(Date:6/19/2013)... , June 19, 2013 Amerivet ... company servicing all branches of government from Federal ... have expanded their facilities to include complex metal ... and fabricated some very complex aluminum parts for ... to expand our capabilities to service government contracts," ...
Breaking Medicine Technology:New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 2New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 3Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3Amerivet Solutions Expands to Manufacture Complex Metal Designs 2
... Pa., Oct. 27, 2011 ViroPharma Incorporated (NASDAQ: ... has signed a definitive agreement to acquire DuoCort ... Sweden focused on improving glucocorticoid replacement therapy.  The ... ViroPharma,s orphan disease commercial product pipeline.  The company ...
... Oct. 27, 2011 ViroPharma Incorporated (Nasdaq: VPHM ) ... 30, 2011. In the third quarter of 2011, we: ... representing 21 percent growth over the third quarter of 2010; ... quarter and $184 million for the 9 month period,  representing Cinryze ...
Cached Medicine Technology:ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline 2ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline 3ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline 4ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline 5ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline 6ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline 7ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 2ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 3ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 4ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 5ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 6ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 7ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 8ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 9ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 10ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 11ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 12
The MESACUP ANA Test Kit is a semi-quantitative enzyme-linked immunosorbent assay,(ELISA) for the detection of specific anti-nuclear antibodies in human serum as an aid in,the determination of autoim...
... HEp-2 cell line that has been genetically ... autoantibodies, without affecting the other ANA patterns ... worldwide on the HEp-2000 ANA substrate, which ... used in place of standard HEp-2 cells ...
... assays can be used to screen ... which are associated with various systemic ... erythematosus (Lupus), Sjgren's syndrome, mixed connective ... polymyositis, dermatomyositis, and Raynaud's phenomenon. They ...
... assays can be used to screen ... which are associated with various systemic ... erythematosus (Lupus), Sjgren's syndrome, mixed connective ... polymyositis, dermatomyositis, and Raynaud's phenomenon. They ...
Medicine Products: